Latest news
Loading news…
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
5
2 exits
Monthly Visits
Available in Pro Contacts
646
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Investor Activity
- Investments
- 5
- Lead investments
- 2
- Portfolio orgs
- 4
- Diversity investments
- 3
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Org types
- company, investor
- HQ
- Palo Alto, California, United States
Investments by BridgeBio
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by BridgeBio
Loading columns…
0 of 0Show
Page 1 / 1
Key People at BridgeBio
Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director
Co-founder
Founder and CEO
Chief Business Officer
President and Chief Operating Officer
SVP, People
Director
Chief Legal Officer
Director, Pricing & Contracting, Market Access
Director and Gene Therapy Product Planning
Chief Operating Officer, Skeletal Dysplasias and Gene Therapy
646
professional contacts at BridgeBio
Contact execs at BridgeBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BridgeBio
Loading news…
FAQs about BridgeBio
People who checked this page also checked these
Sectors BridgeBio invests & acquires in
Browse the full Acquirezy directory.